Own skin cells may speed wound healing and reduce scars

NCT ID NCT07551284

Not yet recruiting Disease control Sponsor: First Affiliated Hospital, Sun Yat-Sen University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether applying a patient's own skin cells (called a basal cell suspension) to surgical wounds can help them heal faster and with less scarring. Researchers will compare 500 people who get this extra treatment with 500 who get standard surgery alone. The goal is to see if the cell spray improves healing within 4 weeks and reduces scar formation over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Autologous epidermal basal cell suspension (a mixture of skin cells from the patient's own skin, applied to wounds to help them heal)
What this could lead to: If it works, this could offer a better way to heal wounds after surgery, with less scarring and faster recovery.
What could go wrong: This is an early observational study, not a controlled trial. The results may not prove the treatment works better than standard care, and there is a risk of infection or poor healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WOUND HEALING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WOUND HEALING

More trials for these conditions

Other studies related to the condition(s) this trial covers.